These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1811993)

  • 1. The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons.
    Rasmussen K; Stockton ME; Czachura JF
    Eur J Pharmacol; 1991 Nov; 205(1):113-6. PubMed ID: 1811993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acute and chronic LY 277359, a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Eur J Pharmacol; 1991 Dec; 209(3):151-6. PubMed ID: 1797560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-HT3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells.
    Minabe Y; Ashby CR; Schwartz JE; Wang RY
    Eur J Pharmacol; 1991 Dec; 209(3):143-50. PubMed ID: 1665793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with DAU 6215, a new 5-HT3 receptor antagonist, causes a selective decrease in the number of spontaneously active dopaminergic neurons in the rat ventral tegmental area.
    Prisco S; Pessia M; Ceci A; Borsini F; Esposito E
    Eur J Pharmacol; 1992 Apr; 214(1):13-9. PubMed ID: 1582449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
    Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 5-HT3 receptor antagonists on the morphine-induced excitation of A10 dopamine cells: electrophysiological studies.
    Gifford AN; Wang RY
    Brain Res; 1994 Feb; 638(1-2):325-8. PubMed ID: 8199870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects produced by acute and chronic treatment with granisetron alone or in combination with haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):127-33. PubMed ID: 1321681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.
    Rasmussen K; Stockton ME; Czachura JF; Howbert JJ
    Eur J Pharmacol; 1991 Dec; 209(1-2):135-8. PubMed ID: 1687681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
    Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Life Sci; 1983 Feb; 32(9):983-93. PubMed ID: 6827927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
    Rasmussen K; Hsu MA; Yang Y
    Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons.
    Sorensen SM; Humphreys TM; Palfreyman MG
    Eur J Pharmacol; 1989 Apr; 163(1):115-8. PubMed ID: 2744086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
    Wachtel SR; White FJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zatosetron on ipecac-induced emesis in dogs and healthy men.
    Schwartz SM; Goldberg MJ; Gidda JS; Cerimele BJ
    J Clin Pharmacol; 1994 Mar; 34(3):250-4. PubMed ID: 7517409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depolarization inactivation of dopamine neurons: an artifact?
    Mereu G; Lilliu V; Vargiu P; Muntoni AL; Diana M; Gessa GL
    J Neurosci; 1995 Feb; 15(2):1144-9. PubMed ID: 7869090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of serotonin3 (5-HT3) receptors within the blood-brain barrier prevents cisplatin-induced emesis in dogs.
    Gidda JS; Evans DC; Cohen ML; Wong DT; Robertson DW; Parli CJ
    J Pharmacol Exp Ther; 1995 May; 273(2):695-701. PubMed ID: 7752072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships.
    Robertson DW; Lacefield WB; Bloomquist W; Pfeifer W; Simon RL; Cohen ML
    J Med Chem; 1992 Jan; 35(2):310-9. PubMed ID: 1732548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with high doses of haloperidol fails to decrease the time course for the development of depolarization inactivation of midbrain dopamine neurons.
    Jiang LH; Tsai M; Wang RY
    Life Sci; 1988; 43(1):75-81. PubMed ID: 3386416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K; Suzuki K; McCreary AC; Ashby CR
    Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
    Santucci V; Gueudet C; Steinberg R; Le Fur G; Soubrié P
    Synapse; 1997 Aug; 26(4):370-80. PubMed ID: 9215596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.